- Home
- CCEL vs BDL Comparison
CCEL vs BDL Comparison
Compare CCEL & BDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- BDL
- Stock Information
- Founded
- CCEL 1989
- BDL 1959
- Country
- CCEL United States
- BDL United States
- Employees
- CCEL N/A
- BDL N/A
- Industry
- CCEL Managed Health Care
- BDL Restaurants
- Sector
- CCEL Health Care
- BDL Consumer Discretionary
- Exchange
- CCEL Nasdaq
- BDL Nasdaq
- Market Cap
- CCEL 51.9M
- BDL 44.1M
- IPO Year
- CCEL 1997
- BDL N/A
- Fundamental
- Price
- CCEL $5.12
- BDL $27.36
- Analyst Decision
- CCEL Strong Buy
- BDL
- Analyst Count
- CCEL 1
- BDL 0
- Target Price
- CCEL $8.50
- BDL N/A
- AVG Volume (30 Days)
- CCEL 10.1K
- BDL 3.7K
- Earning Date
- CCEL 07-14-2025
- BDL 05-19-2025
- Dividend Yield
- CCEL 7.81%
- BDL 3.84%
- EPS Growth
- CCEL N/A
- BDL 14.76
- EPS
- CCEL 0.01
- BDL 2.18
- Revenue
- CCEL $32,102,750.00
- BDL $198,785,000.00
- Revenue This Year
- CCEL $2.49
- BDL N/A
- Revenue Next Year
- CCEL $0.95
- BDL N/A
- P/E Ratio
- CCEL $321.51
- BDL $12.56
- Revenue Growth
- CCEL 2.33
- BDL 9.31
- 52 Week Low
- CCEL $4.75
- BDL $22.61
- 52 Week High
- CCEL $9.43
- BDL $29.25
- Technical
- Relative Strength Index (RSI)
- CCEL 48.65
- BDL 63.58
- Support Level
- CCEL $4.79
- BDL $26.40
- Resistance Level
- CCEL $5.15
- BDL $28.50
- Average True Range (ATR)
- CCEL 0.17
- BDL 0.84
- MACD
- CCEL 0.05
- BDL 0.42
- Stochastic Oscillator
- CCEL 63.79
- BDL 80.67
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About BDL Flanigan's Enterprises Inc.
Flanigan'S Enterprises Inc operates as a chain of small cocktail lounges and packages liquor stores throughout South Florida. The business activity is principally conducted in two segments namely Restaurant and Package liquor store segment. Its Restaurant segment offers alcoholic beverages and full food service, and Package stores consist of retail liquor sales and related items. Its menu consists of a wide variety of options including prime rib, steaks, pasta, entree salads, burgers, a variety of sandwiches, and oversized signature desserts. The company generates maximum revenue from Restaurant segment.